| Susan Lane O'leary, MD | |
|
1470 Medical Pkwy, Suite 160, Carson City, NV 89703-4648 | |
| (775) 445-7650 | |
| (775) 882-4206 |
| Full Name | Susan Lane O'leary |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 24 Years |
| Location | 1470 Medical Pkwy, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760697940 | NPI | - | NPPES |
| 1760697940 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 12741 (Nevada) | Primary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A105681 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Carson Valley Medical Center | Gardnerville, NV | Hospital |
| South Lyon Medical Center | Yerington, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carson Tahoe Physician Clinics | 1153479027 | 83 |
News Archive
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a non-vitamin K antagonist (VKA) oral anticoagulant (NOAC), according to results of the ENSURE-AF trial.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
Scientists from the University of Southampton have discovered that copper and copper alloys rapidly destroy norovirus - the highly-infectious sickness bug.
Researchers at the John Theurer Cancer Center recently published a study delineating the connection of social support to distress after stem cell transplants.
› Verified 3 days ago
| Entity Name | Carson Tahoe Regional Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255360160 PECOS PAC ID: 1759284862 Enrollment ID: O20040128000187 |
News Archive
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a non-vitamin K antagonist (VKA) oral anticoagulant (NOAC), according to results of the ENSURE-AF trial.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
Scientists from the University of Southampton have discovered that copper and copper alloys rapidly destroy norovirus - the highly-infectious sickness bug.
Researchers at the John Theurer Cancer Center recently published a study delineating the connection of social support to distress after stem cell transplants.
› Verified 3 days ago
| Entity Name | Carson Tahoe Physician Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023265717 PECOS PAC ID: 1153479027 Enrollment ID: O20090502000046 |
News Archive
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a non-vitamin K antagonist (VKA) oral anticoagulant (NOAC), according to results of the ENSURE-AF trial.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
Scientists from the University of Southampton have discovered that copper and copper alloys rapidly destroy norovirus - the highly-infectious sickness bug.
Researchers at the John Theurer Cancer Center recently published a study delineating the connection of social support to distress after stem cell transplants.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Lane O'leary, MD Po Box 4390, Carson City, NV 89702-4390 Ph: (775) 445-7650 | Susan Lane O'leary, MD 1470 Medical Pkwy, Suite 160, Carson City, NV 89703-4648 Ph: (775) 445-7650 |
News Archive
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a non-vitamin K antagonist (VKA) oral anticoagulant (NOAC), according to results of the ENSURE-AF trial.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
Scientists from the University of Southampton have discovered that copper and copper alloys rapidly destroy norovirus - the highly-infectious sickness bug.
Researchers at the John Theurer Cancer Center recently published a study delineating the connection of social support to distress after stem cell transplants.
› Verified 3 days ago
Susan J Maturlo, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2874 N Carson St, Suite 120, Carson City, NV 89706 Phone: 775-445-7170 Fax: 775-687-8457 | |
Dr. David M Baker, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1470 Medical Pkwy, Suite 160, Carson City, NV 89703 Phone: 775-445-7650 Fax: 775-687-8457 | |
Dr. Stephen Michael Tann, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1470 Medical Parkway, Suite 160, Carson City, NV 89703 Phone: 775-445-7650 Fax: 775-882-4206 | |
Dr. Larry Angelo Pappas, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1600 Medical Pkwy, Carson City, NV 89703 Phone: 775-445-8000 | |
Dr. Christopher J Dipaolo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1470 Medical Pkwy, Suite 160, Carson City, NV 89703 Phone: 775-445-7650 Fax: 775-687-8457 | |
Richard I Yamamoto, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St, Suite 200, Carson City, NV 89706 Phone: 775-445-7170 Fax: 775-883-0959 | |
Dr. Christopher W Forman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St, Suite 200, Carson City, NV 89706 Phone: 775-445-7170 Fax: 775-883-0959 |